PHARMAXIS has appointed former senior Merck executive Dr Kathleen Metters to its board, with the new director having over 25 years of experience in the development of novel therapies for the treatment of serious diseases.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jun 17